Tags

Type your tag names separated by a space and hit enter

Brazilian Portuguese validation of Mood Disorder Questionnaire.
Compr Psychiatry. 2012 Apr; 53(3):308-12.CP

Abstract

BACKGROUND

The Mood Disorder Questionnaire (MDQ) is a screening instrument for bipolar spectrum disorders already validated in many languages.

METHODS

Patients from 2 psychiatric outpatient facilities were diagnosed with bipolar disorder (BD) type I and II and major depression according to the mood module of the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID), Axis I Disorders--Clinician Version. In addition, a control group of healthy subjects was selected. The diagnostic interviews were used as the gold standard against which to investigate the performance of the MDQ. The MDQ was administered to 153 subjects, distributed among 4 groups. We analyzed the test reliability and discriminative capacity of the MDQ for the detection of patients with BD.

RESULTS

Based on the SCID, Axis I Disorders--Clinician Version, 52 subjects (33.3%) presented a bipolar spectrum disorder (type I, II, or not otherwise specified), 48 (32.4%) were diagnosed as having unipolar depressive disorder, whereas 54 (35.3%) were unaffected by any type of psychiatric disorder (had no psychiatric disorder according to SCID results). The sensitivity for bipolar disorder was 0.72 (bipolar I disorder, 0.81; bipolar II disorder, 0.58; and bipolar disorder not otherwise specified, 0.69), with specificity of 0.95. The Brazilian Portuguese MDQ demonstrated adequate internal consistency (Cronbach α = .87).

LIMITATIONS

Recruiting patients attending tertiary services may inflate the performance of the MDQ.

CONCLUSIONS

The performance of the Brazilian Portuguese MDQ is comparable with other language validations. In a psychiatric outpatient sample, the Brazilian Portuguese MDQ proves to be a feasible and reliable screening instrument.

Authors+Show Affiliations

Federal University of Ceará, Fortaleza, CE, Brazil.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

21632039

Citation

de Sousa Gurgel, Wagner, et al. "Brazilian Portuguese Validation of Mood Disorder Questionnaire." Comprehensive Psychiatry, vol. 53, no. 3, 2012, pp. 308-12.
de Sousa Gurgel W, Rebouças DB, Negreiros de Matos KJ, et al. Brazilian Portuguese validation of Mood Disorder Questionnaire. Compr Psychiatry. 2012;53(3):308-12.
de Sousa Gurgel, W., Rebouças, D. B., Negreiros de Matos, K. J., Carneiro, A. H., & Gomes de Matos e Souza, F. (2012). Brazilian Portuguese validation of Mood Disorder Questionnaire. Comprehensive Psychiatry, 53(3), 308-12. https://doi.org/10.1016/j.comppsych.2011.04.059
de Sousa Gurgel W, et al. Brazilian Portuguese Validation of Mood Disorder Questionnaire. Compr Psychiatry. 2012;53(3):308-12. PubMed PMID: 21632039.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Brazilian Portuguese validation of Mood Disorder Questionnaire. AU - de Sousa Gurgel,Wagner, AU - Rebouças,Diego Barreto, AU - Negreiros de Matos,Karla Julianne, AU - Carneiro,Alexandre Henrique Silva, AU - Gomes de Matos e Souza,Fábio, AU - ,, Y1 - 2011/05/31/ PY - 2011/01/25/received PY - 2011/04/18/revised PY - 2011/04/19/accepted PY - 2011/6/3/entrez PY - 2011/6/3/pubmed PY - 2012/7/17/medline SP - 308 EP - 12 JF - Comprehensive psychiatry JO - Compr Psychiatry VL - 53 IS - 3 N2 - BACKGROUND: The Mood Disorder Questionnaire (MDQ) is a screening instrument for bipolar spectrum disorders already validated in many languages. METHODS: Patients from 2 psychiatric outpatient facilities were diagnosed with bipolar disorder (BD) type I and II and major depression according to the mood module of the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID), Axis I Disorders--Clinician Version. In addition, a control group of healthy subjects was selected. The diagnostic interviews were used as the gold standard against which to investigate the performance of the MDQ. The MDQ was administered to 153 subjects, distributed among 4 groups. We analyzed the test reliability and discriminative capacity of the MDQ for the detection of patients with BD. RESULTS: Based on the SCID, Axis I Disorders--Clinician Version, 52 subjects (33.3%) presented a bipolar spectrum disorder (type I, II, or not otherwise specified), 48 (32.4%) were diagnosed as having unipolar depressive disorder, whereas 54 (35.3%) were unaffected by any type of psychiatric disorder (had no psychiatric disorder according to SCID results). The sensitivity for bipolar disorder was 0.72 (bipolar I disorder, 0.81; bipolar II disorder, 0.58; and bipolar disorder not otherwise specified, 0.69), with specificity of 0.95. The Brazilian Portuguese MDQ demonstrated adequate internal consistency (Cronbach α = .87). LIMITATIONS: Recruiting patients attending tertiary services may inflate the performance of the MDQ. CONCLUSIONS: The performance of the Brazilian Portuguese MDQ is comparable with other language validations. In a psychiatric outpatient sample, the Brazilian Portuguese MDQ proves to be a feasible and reliable screening instrument. SN - 1532-8384 UR - https://www.unboundmedicine.com/medline/citation/21632039/Brazilian_Portuguese_validation_of_Mood_Disorder_Questionnaire_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0010-440X(11)00105-2 DB - PRIME DP - Unbound Medicine ER -